Literature DB >> 18318732

Development of the Gross Motor Function Classification System for cerebral palsy.

Peter L Rosenbaum1, Robert J Palisano, Doreen J Bartlett, Barbara E Galuppi, Dianne J Russell.   

Abstract

The Gross Motor Function Classification System (GMFCS) for cerebral palsy has been widely used internationally for clinical, research, and administrative purposes. This paper recounts the ideas and work behind the creation of the GMFCS, reports on the lessons learned, and identifies some philosophical challenges inherent in trying to develop an ordered, valid, and consistent system to describe function in children and adolescents with developmental differences. It is hoped that these ideas will be useful to others who choose to expand the field with additional systems in other areas of childhood neurodisability.

Entities:  

Mesh:

Year:  2008        PMID: 18318732     DOI: 10.1111/j.1469-8749.2008.02045.x

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  87 in total

Review 1.  New clinical and research trends in lower extremity management for ambulatory children with cerebral palsy.

Authors:  Diane L Damiano; Katharine E Alter; Henry Chambers
Journal:  Phys Med Rehabil Clin N Am       Date:  2009-08       Impact factor: 1.784

2.  Portable Motion-Analysis Device for Upper-Limb Research, Assessment, and Rehabilitation in Non-Laboratory Settings.

Authors:  Won Joon Sohn; Rifat Sipahi; Terence D Sanger; Dagmar Sternad
Journal:  IEEE J Transl Eng Health Med       Date:  2019-11-13       Impact factor: 3.316

3.  Testing the Utility of a Bio-Neuropsychosocial Model for Predicting Medical Adherence and Responsibility During Early Adolescence in Youth With Spina Bifida.

Authors:  Alexandra M Psihogios; Caitlin Murray; Kathy Zebracki; Laura Acevedo; Grayson N Holmbeck
Journal:  J Pediatr Psychol       Date:  2017-10-01

4.  Multimorbidity in Middle-Aged Adults with Cerebral Palsy.

Authors:  Nicole Cremer; Edward A Hurvitz; Mark D Peterson
Journal:  Am J Med       Date:  2017-01-05       Impact factor: 4.965

5.  Developing and validating the Communication Function Classification System for individuals with cerebral palsy.

Authors:  Mary Jo Cooley Hidecker; Nigel Paneth; Peter L Rosenbaum; Raymond D Kent; Janet Lillie; John B Eulenberg; Ken Chester; Brenda Johnson; Lauren Michalsen; Morgan Evatt; Kara Taylor
Journal:  Dev Med Child Neurol       Date:  2011-06-27       Impact factor: 5.449

6.  Focus on function: a cluster, randomized controlled trial comparing child- versus context-focused intervention for young children with cerebral palsy.

Authors:  Mary C Law; Johanna Darrah; Nancy Pollock; Brenda Wilson; Dianne J Russell; Stephen D Walter; Peter Rosenbaum; Barb Galuppi
Journal:  Dev Med Child Neurol       Date:  2011-05-13       Impact factor: 5.449

7.  Data-Driven Classification of Dysarthria Profiles in Children With Cerebral Palsy.

Authors:  Kristen M Allison; Katherine C Hustad
Journal:  J Speech Lang Hear Res       Date:  2018-12-10       Impact factor: 2.297

8.  Gait analysis in children with cerebral palsy via inertial and magnetic sensors.

Authors:  Josien C van den Noort; Alberto Ferrari; Andrea G Cutti; Jules G Becher; Jaap Harlaar
Journal:  Med Biol Eng Comput       Date:  2012-12-09       Impact factor: 2.602

9.  Recumbent cross-training is a feasible and safe mode of physical activity for significantly motor-impaired adults with cerebral palsy.

Authors:  Mark D Peterson; Leah Lukasik; Timothy Muth; Phil Esposito; Heidi Haapala; Paul M Gordon; Heidi IglayReger; Edward A Hurvitz
Journal:  Arch Phys Med Rehabil       Date:  2012-10-10       Impact factor: 3.966

10.  Assessment of brain tissue injury after moderate hypothermia in neonates with hypoxic-ischaemic encephalopathy: a nested substudy of a randomised controlled trial.

Authors:  Mary Rutherford; Luca A Ramenghi; A David Edwards; Peter Brocklehurst; Henry Halliday; Malcolm Levene; Brenda Strohm; Marianne Thoresen; Andrew Whitelaw; Denis Azzopardi
Journal:  Lancet Neurol       Date:  2009-11-05       Impact factor: 44.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.